Neoadjuvant chemoradiation for patients with advanced oesophageal cancer – which response grading system best impacts prognostic discrimination?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant chemoradiation for patients with advanced oesophageal cancer – which response grading system best impacts prognostic discrimination?

Published:2019-03-18 Issue:5 Volume:74 Page:731-743
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Puetz Katharina¹,Bollschweiler Elfriede²³^ORCID,Semrau Robert⁴,Mönig Stefan P²⁵,Hölscher Arnulf H²³,Drebber Uta¹

Affiliation:

1. Institute of Pathology University of Cologne Cologne Germany

2. Department of General, Visceral and Cancer Surgery University of Cologne Cologne Germany

3. Center for Esophageal and Gastric Surgery AGAPLESION Markuskrankenhaus Frankfurt am Main Germany

4. Department of Radiation Oncology University of Cologne Cologne Germany

5. Service de Chirurgie viscérale Hôpitaux Universitaires de Genève Geneva Switzerland

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.13811

Reference36 articles.

1. Epidemiology, diagnosis, and management of esophageal adenocarcinoma;Rubenstein JH;Gastroenterology,2015

2. Preoperative chemoradiotherapy for esophageal or junctional cancer;Hagen P;N. Engl. J. Med.,2012

3. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham D;N. Engl. J. Med.,2006

4. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;Ychou M;J. Clin. Oncol.,2011

5. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction;Davies AR;J. Clin. Oncol.,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective;Pharmacology & Therapeutics;2024-02

2. Perioperative immunotherapy for esophageal squamous cell carcinoma: Now and future;World Journal of Gastroenterology;2023-09-14

3. The effect of histologic grade on neoadjuvant treatment outcomes in esophageal cancer;Journal of Surgical Oncology;2022-05-16

4. Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance;Histopathology;2022-04-06

5. The Impact of Tumor Regression on Prognosis After Neoadjuvant Chemoradiotherapy in Surgically Treated Esophageal Adenocarcinoma;Annals of Surgical Oncology;2022-01-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3